Flazalone
NSAID and cocaine addiction agent
From Wikipedia, the free encyclopedia
Flazalone is an anti-inflammatory drug that has not been approved as a medicine.[1][2][3]
| Clinical data | |
|---|---|
| Other names | Flumefenine, R-760. |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H19F2NO2 |
| Molar mass | 331.363 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Further Analogues
According to Shaomeng Wang and co-workers, replacement of the para-fluoro halogen with a meta,para-dichloro substitution arrangement resulted in dopamine reuptake inhibitors useful in treating cocaine addiction.[4][5] Whereas Diclazalone achieved a Ki of 10.9nM for the mazindol binding site (DAT), flazalone only achieved 5700nM for the same receptor (even weaker than for the phenindamine precursor which was 4420nM). However, the para-methyl compound was the one titled in the article publications. This had a Ki of 492nM for the mazindol binding site (DAT), which is more promising than flazalone if we are only talking about this receptor. For comparison consider WIN 35,428 versus RTI-32.
